STAT June 24, 2024
The results of a randomized controlled trial published Monday showed oral ketamine tablets were safe and effective for patients with treatment-resistant depression — the latest attempt by researchers to rigorously evaluate psychedelic drugs’ role in treating conditions like depression, anxiety, and post-traumatic stress disorder.
In the Phase 2 trial, the findings of which were detailed in Nature Medicine, patients who took extended release ketamine tablets at a...
Today's Sponsors
Today's Sponsor